Back to News
Market Impact: 0.2
GSK (GSK) Q3 Earnings and Revenues Beat Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechAnalyst EstimatesCompany Fundamentals
GSK reported quarterly earnings of $1.47 per share, beating the Zacks Consensus Estimate of $1.40 by $0.07. EPS was down $0.01 from $1.48 a year earlier; the article provides no revenue figures or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
GSK0.35
More News
- UK Budget Tests Bond Markets as Fed, ECB and Oil Risks Loom
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- Wendy's shares jump 15% as Nelson Peltz's Trian offers $1.4 billion to buy burger chain
- GE Vernova shares slip despite a beat-and-raise. What the sellers are getting wrong
- Microsoft's Big Bets on AI Start to Pay Off